Brian A Costell MD

Neurology•Boca Raton, FL

Epilepsy, Headache, Movement Disorder

Brian Costell, MD has championed a comprehensive approach to patient care and overall patient well-being. By bringing Neurology, Neuropsychology, Infusion Therapies, and Clinical Research under one roof in Boca Raton, Florida, Dr. Brian Costell has established the continuum of care resulting in a more efficient and more effective patient experience.

Join to View Full Profile

9970 Central Park Blvd NSuite 207Boca Raton, FL 33428
Phone+1 561-482-1027
Fax+1 561-482-1028

Summary

Dr. Brian Costell is a neurologist in Boca Raton, FL and is affiliated with multiple hospitals in the area, including Broward Health Coral Springs and West Boca Medical Center. He received his medical degree from Ponce Health Sciences University and has been in practice 19 years. He also speaks multiple languages, including Spanish. He specializes in headache and neurophysiology and is experienced in electromyography and clinical neurophysiology.

Education & Training

NYU Grossman School of MedicineFellowship, Clinical Neurophysiology, 2003 - 2004
Tulane UniversityResidency, Internal Medicine/Neurology, 1998 - 2003
Ponce Health Sciences University School of MedicineClass of 1998

Certifications & Licensure

FL State Medical License 2004 - 2026
LA State Medical License 2000 - 2005
NY State Medical License 2003 - 2005
American Board of Psychiatry and Neurology Neurology

Clinical Trials

Simufilam 100 Mg for Mild-to-Moderate Alzheimer's Disease Start of enrollment: 2021 Nov 03
COMPLETED
PHASE3
A Study of LY3372689 to Assess the Safety, Tolerability, and Efficacy in Participants With Alzheimer's Disease Start of enrollment: 2021 Sep 16
ACTIVE_NOT_RECRUITING
PHASE2
A Donanemab (LY3002813) Prevention Study in Participants With Alzheimer's Disease (TRAILBLAZER-ALZ 3) Start of enrollment: 2021 Aug 27
Recruiting
Phase 3
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study to Assess STS101 in the Acute Treatment of Migraine Start of enrollment: 2021 Jun 30
Completed
Phase 3
A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2) Start of enrollment: 2020 Jun 19
ACTIVE_NOT_RECRUITING
PHASE3
Extension Study to Evaluate the Long-Term Safety and Tolerability of Oral Atogepant for the Prevention of Migraine in Participants With Episodic Migraine Start of enrollment: 2019 May 06
Completed
Phase 3
A Study to Evaluate the Efficacy and Safety of Oral Zavegepant in Migraine Prevention Start of enrollment: 2021 Mar 26
TERMINATED
PHASE2, PHASE3
12-Week Placebo-controlled Study of Atogepant for the Preventive Treatment of Migraine in Participants With Episodic Migraine Start of enrollment: 2018 Dec 14
Completed
Phase 3
Randomized Trial in Adult Participants With Acute Migraines Start of enrollment: 2020 Oct 27
Completed
Phase 3
Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type Start of enrollment: 2015 Dec 01
Recruiting
Phase 3
Computerized Cognitive Rehabilitation in MS Patients Start of enrollment: 2021 Apr 21
Recruiting
Not Applicable
Placebo-Controlled Study to Investigate the Efficacy & Safety of Injectafer in the Treatment of RLS Start of enrollment: 2015 Jan 01
Completed
Phase 3
Study Describing Cognitive Processing Speed Changes in Relapsing Multiple Sclerosis Subjects Treated With Ozanimod (RPC-1063) Start of enrollment: 2020 Jan 16
ACTIVE_NOT_RECRUITING
PHASE3
Join now to see all

Other Languages

Spanish

External Links

First Choice Neurology Biohttp://neurologyoffices.com